reported that the application of MSC-EVs restored the stability of TFAM and TFAM–mtDNA complexes, thereby reversing damage caused by mitochondrial oxidative phosphorylation in renal tubular cells and alleviating kidney inflammation (121). Here, TFAM is linked to urogenital neoplasm.